TP53 and colonic neoplasm: We found that indeed, cells carrying the SMARCC1 C520E mutation demonstrate a significant decrease in the expression of p53-regulated cell cycle genes, which we found to be downregulated following DNA damage in colon cancer cells expressing ASS1 (Fig. 4h and Extended Data Fig. 4f,g).